YDUQS stock gained 4.41 percent as Afya merger reshapes group

Published on 10/07/2026 at 02:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

YDUQS stock stood at BRL 13.01 on October 6, 2026, with a 4.41 percent daily change. The Afya deal gives YDUQS shareholders 31 percent of the combined group.

YDUQS, BRYDUQACNOR3, Illustration mit AI erstellt.

YDUQS stock (ISIN BRYDUQACNOR3) was last at BRL 13.01 on B3 on October 6, 2026, at 5:05 p.m. BRT, up 4.41 percent from the prior close of BRL 12.46. The move came as investors continued to assess the planned combination with Afya, which was announced on September 23, 2026.

Afya deal changes the scale

According to Valor, YDUQS shareholders would retain 31 percent of the combined education group and receive a minimum of BRL 750 million in dividends. The transaction would create a business with BRL 9.4 billion in net revenue and BRL 3.6 billion in adjusted EBITDA for the 12 months ended June 2026.

The same transaction profile assigns 55 percent of combined net revenue and 66 percent of adjusted EBITDA to premium businesses, including medical education and Ibmec. Completion requires shareholder approval and clearance from Brazil's antitrust regulator, while the stated deadline is March 31, 2028.

Analyst target moved to BRL 17

According to El Fondo, Bradesco BBI reiterated an Outperform rating on September 18, 2026, and raised its target from BRL 15 to BRL 17. The bank increased its 2027 adjusted net income projection by 4 percent to BRL 442 million and its cash generation estimate by 12 percent to BRL 426 million.

Bradesco BBI also projected YDUQS net revenue growth of 3.7 percent year over year in the second half of 2026. Its price-to-earnings estimate was 5.9 times, 17 percent below the historical average used in the report, making the merger's execution and operating recovery the key valuation variables.

Stock remains below yearly high

YDUQS had a market capitalization of BRL 3.4 billion and traded 7,363,300 shares on October 6, 2026. Its 52-week range was BRL 7.02 to BRL 15.29, putting the latest price 14.91 percent below the yearly high.

The company investor-relations page identifies its latest results item as Q2 2026 and includes 2026 guidance. It also lists the next results publication for November 12, 2026, after the market closes, making that date the next scheduled checkpoint for the stock.

YDUQS stock faces a results checkpoint

At BRL 13.01 on October 6, 2026, YDUQS stock remained below its 52-week high while the Afya transaction supplied the central corporate valuation question. The November 12 results date will put the 2026 operating outlook against the merger assumptions.